The COVID-19 pandemic led to a surge in late-stage cancer diagnoses, with restrictions preventing or discouraging many from getting screened early. But a new screening technology developed by a Canadian company could make it easier to detect cancers earlier.
StageZero Life Sciences is a Richmond Hill, Ont.-based health care company that has developed a way to simultaneously screen for a wide variety of cancers using a single blood sample. Some of the cancers that StageZero can detect include breast, cervical, endometrial, prostate, liver, stomach, bladder and colorectal.
“We’re adding a whole series of additional ones. And as we continue to build out, we’ll continue to add to them,” StageZero Chairman and CEO James Howard-Tripp told CTV News Channel on Saturday.
Full Article: ctvnews.ca